A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.
机构:[1]Division of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.[2]Department of Medical Oncology, Chinese Academy of Medical Sciences Cancer Institute and Hospital, Beijing, China.[3]Department of Thoracic Oncology, Jilin Provincial Tumor Hospital, Changchun, China.[4]Division of Oncology, Linyi Cancer Hospital, Linyi, China.[5]Division of Pulmonary Medicine, The First Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.[6]Division of Oncology, Tangdu Hospital, Xi'an, China.[7]Thoracic Surgery, Yunnan Cancer Hospital, Kunming, China.[8]Division of Oncology, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China.河北医科大学第四医院[9]Division of Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.[10]Division of Thoracic Oncology, Sichuan University West China Hospital, Chengdu, China.四川大学华西医院[11]Division of Oncology, Capital Medical University Beijing Chest Hospital, Beijing, China.[12]Cancer Center, Jilin University First Hospital, Changchun, China.
第一作者机构:[1]Division of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[*1]Department of Medical Oncology, Chinese Academy of Medical Sciences Cancer Hospital, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.[*2]Division of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, No. 1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China.
推荐引用方式(GB/T 7714):
Si Xiaoyan,Wang Jinwan,Cheng Ying,et al.A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.[J].THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.2020,12:doi:10.1177/1758835920965849.
APA:
Si Xiaoyan,Wang Jinwan,Cheng Ying,Shi Jianhua,Cui Liying...&Zhang Li.(2020).A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer..THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY,12,
MLA:
Si Xiaoyan,et al."A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.".THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 12.(2020)